Antibody-drug conjugates for targeted cancer therapy: Recent advances in potential payloads.
Xi M, Zhu J, Zhang F, Shen H, Chen J, Xiao Z, Huangfu Y, Wu C, Sun H, Xia G.
Eur J Med Chem · review; journal article · DOI 10.1016/j.ejmech.2024.116709 PUBLIKATIONSREGISTRET
Gå till forskningen.
Publikationsdata från Europe PMC och PubMed. Följ källhänvisningar från ämnesregistret till originalpublikationerna.
Publikationer som ChEBI hänvisar till för dolastatin-10. Visa hela publikationsregistret
En publikationsträff är inte en slutsats. Publikationslistan visar bibliografiska uppgifter. Eventuella forskningsutdrag visas separat med originalunderlag. En källhänvisning visar inte i sig effekt, dosering eller säkerhet.
Publikationer i urvalet
19 träffarDiscovery and Development of Dolastatin 10-Derived Antibody Drug Conjugate Anticancer Drugs.
Singh SB.
J Nat Prod · review; journal article · DOI 10.1021/acs.jnatprod.1c01135Marine Invertebrate Natural Products that Target Microtubules.
Miller JH, Field JJ, Kanakkanthara A, Owen JG, Singh AJ, Northcote PT.
J Nat Prod · research support, non-u.s. gov't; review; journal article · DOI 10.1021/acs.jnatprod.7b00964Antineoplastic Agents. 605. Isoquinstatins.
Pettit GR, Melody N, Chapuis JC.
J Nat Prod · research support, non-u.s. gov't; journal article · DOI 10.1021/acs.jnatprod.7b00352Antineoplastic Agents. 604. The Path of Quinstatin Derivatives to Antibody Drug Conjugates.
Pettit GR, Melody N, Chapuis JC.
J Nat Prod · journal article · DOI 10.1021/acs.jnatprod.7b00237Caldoramide, a Modified Pentapeptide from the Marine Cyanobacterium Caldora penicillata.
Gunasekera SP, Imperial L, Garst C, Ratnayake R, Dang LH, Paul VJ, Luesch H.
J Nat Prod · research support, non-u.s. gov't; research-article; journal article; research support, n.i.h., extramural · DOI 10.1021/acs.jnatprod.6b00203Targeted natural products discovery from marine cyanobacteria using combined phylogenetic and mass spectrometric evaluation.
Salvador-Reyes LA, Engene N, Paul VJ, Luesch H.
J Nat Prod · research support, non-u.s. gov't; research-article; research support, u.s. gov't, non-p.h.s.; journal article; research support, n.i.h., extramural · DOI 10.1021/np500931qA synthetic dolastatin 10 analogue suppresses microtubule dynamics, inhibits cell proliferation, and induces apoptotic cell death.
Gajula PK, Asthana J, Panda D, Chakraborty TK.
J Med Chem · research support, non-u.s. gov't; journal article · DOI 10.1021/jm3009629Antimalarials from nature.
Kaur K, Jain M, Kaur T, Jain R.
Bioorg Med Chem · review; journal article · DOI 10.1016/j.bmc.2009.02.050Total synthesis and biological evaluation of ustiloxin natural products and two analogs.
Li P, Evans CD, Forbeck EM, Park H, Bai R, Hamel E, Joullié MM.
Bioorg Med Chem Lett · research support, non-u.s. gov't; research support, u.s. gov't, non-p.h.s.; journal article; research support, n.i.h., extramural · DOI 10.1016/j.bmcl.2006.06.071Antineoplastic agents. 515. Synthesis of human cancer cell growth inhibitors derived from 3,4-methylenedioxy-5,4'-dimethoxy-3'-amino-Z-stilbene.
Pettit GR, Anderson CR, Gapud EJ, Jung MK, Knight JC, Hamel E, Pettit RK.
J Nat Prod · research support, u.s. gov't, p.h.s.; research support, non-u.s. gov't; research-article; journal article; research support, n.i.h., extramural · DOI 10.1021/np058033lIsolation of dolastatin 10 from the marine cyanobacterium Symploca species VP642 and total stereochemistry and biological evaluation of its analogue symplostatin 1.
Luesch H, Moore RE, Paul VJ, Mooberry SL, Corbett TH.
J Nat Prod · research support, u.s. gov't, p.h.s.; journal article · DOI 10.1021/np010049ySynthesis and antiproliferative activity of a cyclic analog of dolastatin 10.
Poncet J, Hortala L, Busquet M, Guéritte-Voegelein F, Thoret S, Pierré A, Atassi G, Jouin P.
Bioorg Med Chem Lett · journal article · DOI 10.1016/s0960-894x(98)00511-3Symplostatin 1: A dolastatin 10 analogue from the marine cyanobacterium Symploca hydnoides.
Harrigan GG, Luesch H, Yoshida WY, Moore RE, Nagle DG, Paul VJ, Mooberry SL, Corbett TH, Valeriote FA.
J Nat Prod · research support, u.s. gov't, p.h.s.; journal article · DOI 10.1021/np980321cSynthesis and biological activity of chimeric structures derived from the cytotoxic natural compounds dolastatin 10 and dolastatin 15.
Poncet J, Busquet M, Roux F, Pierré A, Atassi G, Jouin P.
J Med Chem · comparative study; research support, non-u.s. gov't; journal article · DOI 10.1021/jm970800tSynthesis of Dolastatin 15 mimetic peptoids.
Schmitt J, Bernd M, Kutscher B, Kessler H.
Bioorg Med Chem Lett · research support, non-u.s. gov't; journal article · DOI 10.1016/s0960-894x(98)00034-1Progress in the discovery of biosynthetic anticancer drugs.
Pettit GR.
J Nat Prod · research support, u.s. gov't, p.h.s.; research support, non-u.s. gov't; review; journal article · DOI 10.1021/np9604386Competition of hydrophobic peptides, cytotoxic drugs, and chemosensitizers on a common P-glycoprotein pharmacophore as revealed by its ATPase activity.
Borgnia MJ, Eytan GD, Assaraf YG.
J Biol Chem · research support, non-u.s. gov't; journal article · DOI 10.1074/jbc.271.6.3163Chiral modifications of dolastatin 10: the potent cytostatic peptide (19aR)-isodolastatin 10.
Pettit GR, Singh SB, Hogan F, Burkett DD.
J Med Chem · research support, u.s. gov't, p.h.s.; research support, non-u.s. gov't; research support, u.s. gov't, non-p.h.s.; journal article · DOI 10.1021/jm00174a006